beta

IART

Integra LifeSciences Holdings Corp.

Iart

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Integra LifeSciences Holdings Corp. engages in the manufacture and sale of medical instruments, devices, and equipment. It operates through the Codman Specialty Surgical, and Orthopedics and Tissue Technologies segments. The Codman Specialty Surgical segment refers to the company's neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and precision tools and instruments business, which sells instrument patterns and surgical and lighting products to hospitals, surgery centers, and dental, podiatry, and veterinary offices. The Orthopedics and Tissue Technologies segment includes offerings such as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Plainsboro, NJ.

Market Cap: 5.01 Billion

Primary Exchange: NASDAQ

Website: http://www.integralife.com

Shares Outstanding: 85.9 Million

Float: 71.5 Million

Dividend: (%)

Beta: 1.0301351259133

Sector: Health Technology

Industry: Medical Specialties

Short Interest (Jan 12, 2018): 4.99 Million

Ethical Flags

Animal testing

Longest drawdown: 494 trading days

From: 2018-06-15 To: 2019-11-12

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2017-01-04 2016-12-22 2016-12-21 2017-01-03 00:00:00 -0500 0.5 2.0 1.0
Data provided by IEX Cloud